Molecular subtypes of colorectal cancer in pre-clinical models show differential response to targeted therapies: Treatment implications beyond KRAS mutations
暂无分享,去创建一个
S. Paik | K. Pogue-Geile | Rim S. Kim | A. Srinivasan | C. Allegra | J. C. Schmitz | Ying Wang | N. Song | P. Gavin | S. Jacobs | R. Pal | Shaoyu Wu | Ning Wei | P. C. Lucas